-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Ensysce Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2017 to Q2 2025.
- Ensysce Biosciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2025 was -$1.75M, a 10.5% increase year-over-year.
- Ensysce Biosciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2025 was -$6.65M, a 31.2% increase year-over-year.
- Ensysce Biosciences, Inc. annual Operating Income (Loss) for 2024 was -$6.73M, a 37.2% increase from 2023.
- Ensysce Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$10.7M, a 55.8% increase from 2022.
- Ensysce Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$24.2M, a 21.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)